EVE Health Group Limited (ASX:EVE)

Verve Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	8	5	5	5	15	22
Market Cap Growth	-	-	4.44%	-67.15%	-31.24%	86.83%
Enterprise Value	8	6	5	5	11	22
Last Close Price	0.03	0.04	0.04	0.04	0.13	0.20
PS Ratio	4.18	2.47	2.26	2.51	5.49	9.67
PB Ratio	20.07	4.31	1.69	0.73	1.51	1.72
P/TBV Ratio	20.07	4.31	1.69	0.74	1.66	1.86
EV/Sales Ratio	4.06	2.58	2.26	2.56	4.08	9.45
Debt / Equity Ratio	0.36	0.06	0.00	0.07	0.10	0.05
Asset Turnover	0.87	0.64	0.38	0.20	0.22	0.20
Inventory Turnover	4.24	3.78	1.59	1.02	1.61	3.41
Quick Ratio	0.83	0.14	0.29	1.72	3.68	10.23
Current Ratio	1.85	1.94	4.08	3.66	4.94	11.74
Return on Equity (ROE)	-105.17%	-71.22%	-46.72%	-59.79%	-31.32%	-25.48%
Return on Assets (ROA)	-38.07%	-29.61%	-24.07%	-25.94%	-18.20%	-15.01%
Return on Capital (ROIC)	-56.73%	-44.52%	-27.83%	-27.84%	-19.13%	-16.58%
Earnings Yield	-21.01%	-36.04%	-76.67%	-106.36%	-23.62%	-10.74%
FCF Yield	-	-20.99%	-31.30%	-75.20%	-16.31%	-15.56%
Buyback Yield / Dilution	0.51%	-1.07%	-30.10%	-4.94%	-22.54%	-35.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.